Insider · CIK 0001250195
Steve Elms
director
Files at MRKR (Marker Therapeutics, Inc.), ADMA (ADMA BIOLOGICS, INC.), ELEV (Elevation Oncology, Inc.). First filing Dec 26, 2024, latest Mar 9, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 1
$253k bought, $8.8M sold
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
ADMA: ADMA BIOLOGICS, INC.
ADMAOct 9, 2026 · close 10.36
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
MRKR: Marker Therapeutics, Inc.
MRKROct 9, 2026 · close 0.97
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | ADMAbuy ADMA BIOLOGICS, INC. | $217k 14,000 shares | +1% | +12% from low-36% from high | |
| 45Moderate | ADMA BIOLOGICS, INC. | $8.8M 425,621 shares | -20% | +40% from low-12% from high | |
| 29Weak | Marker Therapeutics, Inc. | $35k 11,085 shares | +4% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | ADMA ADMA BIOLOGICS, INC. | POpen-market purchase Common Stockindirect: See footnote | +7,000 | $15.67 | $110k | 2,038,730 | Mar 9, 2026 |
| Mar 6, 2026 | ADMA ADMA BIOLOGICS, INC. | POpen-market purchase Common Stockindirect: See footnote | +7,000 | $15.39 | $108k | 2,045,730 | Mar 9, 2026 |
| Feb 9, 2026 | ADMA ADMA BIOLOGICS, INC. | AGrant or award Common Stock | +10,690 | $0.00 | $0 | 98,020 | Feb 11, 2026 |
| Feb 9, 2026 | ADMA ADMA BIOLOGICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +17,730 | $0.00 | $0 | 17,730 | Feb 11, 2026 |
| Nov 17, 2025 | MRKR Marker Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +84,411 | $0.00 | $0 | 84,411 | Nov 19, 2025 |
| Nov 17, 2025 | MRKR Marker Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +137,330 | $0.00 | $0 | 137,330 | Nov 19, 2025 |
| Jul 23, 2025 | ELEV Elevation Oncology, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: See footnote | -31,238 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | ELEV Elevation Oncology, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: See footnote | -15,619 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | ELEV Elevation Oncology, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: See footnote | -31,238 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | ELEV Elevation Oncology, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: See footnote | -35,000 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | ELEV Elevation Oncology, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: See footnote | -35,000 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jun 12, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stockindirect: See footnote | -92,941 | $21.69 | $2.0M | 2,031,730 | Jun 16, 2025 |
| Jun 13, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock | +9,000 | $5.96 | $54k | 96,330 | Jun 16, 2025 |
| Jun 13, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock | +10,000 | $5.00 | $50k | 106,330 | Jun 16, 2025 |
| Jun 13, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock | +53,837 | $3.66 | $197k | 160,167 | Jun 16, 2025 |
| Jun 13, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock | +17,500 | $4.91 | $86k | 177,667 | Jun 16, 2025 |
| Jun 13, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock | +30,000 | $3.89 | $117k | 207,667 | Jun 16, 2025 |
| Jun 13, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock | +15,000 | $2.92 | $44k | 222,667 | Jun 16, 2025 |
| Jun 13, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock | +55,000 | $2.35 | $129k | 277,667 | Jun 16, 2025 |
| Jun 13, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock | +53,172 | $1.67 | $89k | 330,839 | Jun 16, 2025 |
| Jun 13, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock | +51,630 | $3.35 | $173k | 382,469 | Jun 16, 2025 |
| Jun 13, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stock | +37,541 | $5.40 | $203k | 420,010 | Jun 16, 2025 |
| Jun 13, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock | -137,931 | $20.82 | $2.9M | 282,079 | Jun 16, 2025 |
| Jun 16, 2025 | ADMA ADMA BIOLOGICS, INC. | SOpen-market sale Common Stock | -194,749 | $20.24 | $3.9M | 87,330 | Jun 16, 2025 |
| Jun 13, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -9,000 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 13, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -10,000 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 13, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -53,837 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 13, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -17,500 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 13, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -30,000 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 13, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -15,000 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 13, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -55,000 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 13, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -53,172 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 13, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -51,630 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 13, 2025 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -37,541 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 5, 2025 | ELEV Elevation Oncology, Inc. | AGrant or award Stock Option (Right to Buy)derivativeindirect: See footnote | +35,000 | $0.00 | $0 | 35,000 | Jun 9, 2025 |
| Feb 19, 2025 | ADMA ADMA BIOLOGICS, INC. | AGrant or award Common Stock | +10,889 | $0.00 | $0 | 87,330 | Feb 21, 2025 |
| Feb 19, 2025 | ADMA ADMA BIOLOGICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +16,279 | $0.00 | $0 | 16,279 | Feb 21, 2025 |
| Feb 12, 2025 | MRKR Marker Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Feb 14, 2025 |
| Dec 23, 2024 | MRKR Marker Therapeutics, Inc. | POpen-market purchase Common Stockindirect: See Footnote | +11,085 | $3.20 | $35k | 325,370 | Dec 26, 2024 |
| Nov 27, 2024 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Common Stockindirect: See footnote | +9,000 | $10.80 | $97k | 2,124,671 | Dec 2, 2024 |
| Nov 27, 2024 | ADMA ADMA BIOLOGICS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -9,000 | $0.00 | $0 | 0 | Dec 2, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.